SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MARCHETTI, Giovanna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.949
EU - Europa 2.532
AS - Asia 1.705
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 3
SA - Sud America 1
Totale 13.202
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.935
CN - Cina 968
UA - Ucraina 707
DE - Germania 545
TR - Turchia 415
IT - Italia 381
GB - Regno Unito 274
SG - Singapore 219
SE - Svezia 217
FI - Finlandia 149
PL - Polonia 91
HK - Hong Kong 40
BE - Belgio 35
FR - Francia 31
CZ - Repubblica Ceca 30
RU - Federazione Russa 29
NL - Olanda 15
ID - Indonesia 14
IN - India 14
CA - Canada 12
VN - Vietnam 12
IR - Iran 10
IE - Irlanda 6
JP - Giappone 6
AU - Australia 4
CH - Svizzera 4
EU - Europa 4
NZ - Nuova Zelanda 3
PT - Portogallo 3
RO - Romania 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
DZ - Algeria 2
GR - Grecia 2
HU - Ungheria 2
MX - Messico 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
CL - Cile 1
DK - Danimarca 1
IL - Israele 1
KR - Corea 1
MA - Marocco 1
MK - Macedonia 1
MT - Malta 1
RS - Serbia 1
Totale 13.202
Salva come PNG Salva come JPEG
Città #
Fairfield 1.044
Woodbridge 1.044
Chandler 780
Jacksonville 773
Houston 756
Ann Arbor 622
Ashburn 544
Seattle 428
Wilmington 406
Cambridge 378
Izmir 257
Nanjing 242
Boardman 178
Princeton 171
Beijing 144
New York 130
Ferrara 129
Singapore 115
San Diego 107
Warsaw 90
Milan 79
Shanghai 70
Nanchang 69
Shenyang 68
Dearborn 63
Bremen 62
Hebei 57
Tianjin 47
San Mateo 45
Jiaxing 44
Düsseldorf 43
Changsha 40
Falls Church 38
Hong Kong 36
Brussels 32
Jinan 32
Kunming 30
Addison 28
Norwalk 28
Redwood City 28
Brno 27
Munich 26
Auburn Hills 22
London 20
Des Moines 19
Mountain View 19
Zhengzhou 17
Ningbo 15
Guangzhou 14
Jakarta 14
Augusta 13
Rome 13
Dong Ket 12
Los Angeles 12
Mcallen 12
Orange 12
Washington 12
Hangzhou 11
Helsinki 11
Taizhou 11
Indiana 10
Philadelphia 10
Verona 10
Leawood 8
Montréal 8
Ardabil 7
Florence 7
Haikou 7
Lanzhou 7
Monmouth Junction 7
Amsterdam 6
Hounslow 6
Padova 6
Redmond 6
Fuzhou 5
Taiyuan 5
Castelcovati 4
Changchun 4
Hanover 4
Hefei 4
Nutley 4
Pune 4
Sala 4
Shenzhen 4
Tappahannock 4
Bologna 3
Dublin 3
Lusia 3
Mülheim-kärlich 3
Pregassona 3
Albignasego 2
Asti 2
Athens 2
Atlanta 2
Auckland 2
Catania 2
Cento 2
Chengdu 2
Chicago 2
Chiswick 2
Totale 9.775
Salva come PNG Salva come JPEG
Nome #
Are Plasma Levels of Vascular Adhesion Protein-1 Associated Both with Cerebral Microbleeds in Multiple Sclerosis and Intracerebral Haemorrhages in Stroke? 189
C6orf10 low-frequency and rare variants in italian multiple sclerosis patients 179
Hemostasis biomarkers in multiple sclerosis 144
An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis 143
Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile 141
VITAMIN K-INDUCED MODIFICATION OF COAGULATION PHENOTYPE IN VKORC1 HOMOZYGOUS DEFICIENCY 137
Genetic determinants of activated factor VII antithrombin complex plasma concentration include tissue factor, factor VII and endothelial protein C receptor gene variants 130
Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis 127
null 125
Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantation 123
null 121
Taqi polymorphism at the human coagulation factor XII locus (F12) 121
Calmodulin expression distinguishes the smooth muscle cell population of human carotid plaque 121
U1snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 120
Characterization and mapping of the 5′ portion of von Willebrand factor pseudogene 119
The effectiveness of Robot-Assisted Gait Training versus conventional therapy on mobility in severely disabled progressIve MultiplE sclerosis patients (RAGTIME): Study protocol for a randomized controlled trial 118
Plasma levels of soluble NCAM in multiple sclerosis 118
The F11 rs2289252 polymorphism is associated with FXI activity levels and APTT ratio in women with thrombosis 116
A heparin cofactor II mutation (HCII Rimini) combined with factor V Leiden or type I protein C deficiency in two unrelated thrombophilic subjects 115
Effective hemostasis during minor surgery in a case of hereditary combined deficiency of vitamin K-dependent clotting factors 114
A novel mutation (Leu817Pro) causing type 2A von Willebrand disease. 113
Membrane binding and anticoagulant properties of protein S natural variants 112
How to evaluate phenotype-genotype relationship in rare coagulation haemorrhagic disorders: examples from FVII deficiency 112
Molecular defects in CRM+ factor VII deficiencies: modelling of missense mutations in the catalytic domain of FVII 112
The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease 111
Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene cluster 109
Partial gene deletion in a family with factor X deficiency 109
FV multiallelic marker detects genetic components of APC resistance contributing to venous thromboembolism in FV Leiden carriers 108
Detection and characterization of polymorphic markers in the factor-VII gene. 108
Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain function 106
Factor XII gene alteration in Hageman trait detected by TaqI restriction enzyme 106
Coagulation Factor XII Levels and Intrinsic Thrombin Generation in Multiple Sclerosis 105
Mutation pattern in clinically asymptomatic coagulation factor VII deficiency 104
Factor VII mutant V154G models a zymogen-like form of factor VIIa 103
PRIMARY INTRAVASCULAR SYNOVIAL SARCOMA OF THE FEMORAL VEIN IN A MALE PATIENT, CASE REPORT 103
New coagulation factor V gene polymorphisms define a single and infrequent haplotype underlying the factor V leiden mutation in Mediterranean populations and Indians 103
A polymorphism in the 5′ region of coagulation factor VII gene (F7) caused by an inserted decanucleotide 103
Characterization of polymorphic markers in the von Willebrand factor gene and pseudogene 103
A "de novo" Gene Deletion and New RFLPs Detected by von Willebrand Factor cDNA. 102
A De Novo and Heterozygous Gene Deletion Causing a Variant of von Willebrand Disease 101
null 100
Impaired prothrombinase activity of factor X Gly381 Asp results in severe familial CRM+ FX deficiency 100
Molecular bases of CRM+ factor X deficiency: a frequent mutation (Ser334Pro) in the catalytic domain and a substitution (Glul02Lys) in the second EGF‐like domain 99
Human leukemia K562 cells: Relationship between hemin-mediated erythroid induction, cell proliferation and expression of c-abl and c-myc oncogenes 99
Clinical picture and management of congenital factor VII deficiency 98
Symptomatic type II protein C deficiency caused by a missense mutation (Gly 381-->Ser) in the substrate-binding pocket 98
Molecular mechanisms of FVII deficiency: expression of mutations clustered in the IVS7 donor splice site of factor VII gene. 97
null 96
Risks factors for highly unstable response to oral anticoagulation: a case-control study 96
null 96
Organization of α-Globin Genes and mRNA Translation in Subjects Carrying Haemoglobin Hasharon (α47 Asp → His) from the Ferrara Region (Northern Italy) 95
CHARACTERIZATION OF THE PSEUDOGENIC REGION OF VON WILLEBRAND FACTOR BY MOLECULAR CLONING AND "IN SITU" HYBRIDIZATION 95
null 95
Modulation of factor VII levels by intron 7 polymorphisms: Population and in vitro studies 95
Characterization of the intracellular signalling capacity of natural FXa mutants with reduced pro-coagulant activity 95
Rapid detection of a protein C gene mutation present in the asymptomatic and not in the thrombosis‐prone lineage 94
PCR and specific oligonucleotide hybridization for the molecular characterization and carrier detection of hemophilia A. 94
Deletion of exons 26-34 (domain D3-A3) of von Willebrand-factor gene in the von Willebrand disease type-II. 94
null 94
Hyperhomocyst(e)inemia and a common methylenetetrahydrofolate reductase mutation (Ala(223)Val MTHFR) in patients with inherited thrombophilic coagulation defects 93
Protein S mRNA in patients with protein S deficiency. 91
Novel phenotype and gamma-glutamyl carboxylase mutations in combined deficiency of vitamin K-dependent coagulation factors 91
Increased CCL18 plasma levels are associated with neurodegenerative MRI outcomes in multiple sclerosis patients 91
Expression profiles of the internal jugular and saphenous veins: Focus on hemostasis genes 90
Non-conventional therapeutic strategies for inherited disorders oh hemostasis 89
Detection of two missense mutations and characterization of a repeat polymorphism in the factor VII gene (F7) 89
A DE NOVO GENE ALTERATION CAUSING VON WILLEBRAND DISEASE 87
Reduced activation of the Gla19Ala FX variant via the extrinsic coagulation pathway results in symptomatic CRMred FX deficiency 87
Oral contraceptives highlight the genotype-specific association between serum phospholipids and activated factor VII 87
null 86
Human protein S circulates in plasma partially bund to LDL and HDL: do PS-lipoprotein complexes mediate PS delivery within atherosclerotic plaque? 85
2 TAQI RFLPS IN THE HUMAN VONWILLEBRAND-FACTOR GENE 83
Modulation of thrombophilia genes by environmental factors 82
Molecular analysis of factor VII deficiency in Italy: a frequent mutation (FVII Lazio) in a repeated intronic region 82
null 82
Sublocalization of von Willebrand Factor Pseudogene in 22q11.22-q11.23 and Detection of two TaqI RFLPs. 82
Interaction of occupational posture, lifestyle and genetic components of thrombophilia 82
In-Frame Deletion of von Willebrand Factor Exons 26-34 (D3-A3 Domains) in Type II von Willebrand Disease. 81
β+-thalassaemia in the Po river delta region (northern Italy): Genotype and β globin synthesis 79
c-myc oncogene alterations in human thyroid carcinomas. 79
DECAY OF BETA-GLOBIN SYNTHESIS IN HETEROZYGOUS BETA-O-FERRARA THALASSEMIA 78
Two novel mutations (Pro864His, Val867Glu) causing type 2A von Willebrand disease and affecting a single restriction site in exon 28. 78
Localization of cloned human DNA sequences and analysis of chromosomal alterations by in situ hybridization. 78
Detection of new polymorphic markers in the factor V gene: Association with factor V levels in plasma 77
Angiotensin-converting enzyme gene polymorphism made risk of restenosis after coronary stenting 77
CHROMOSOMAL LOCALIZATION AND CHARACTERIZATION OF RFLPs IN THE VON WILLEBRAND FACTOR PSEUDOGENE 76
Molecular Characteristics of a Non-deletion α-Thalassaemia of the Po River Delta 76
2 ADDITIONAL TAQI RFLPS IN VONWILLEBRAND-FACTOR GENE (VWF) AND PSEUDOGENE 75
Functional recovery in multiple sclerosis patients undergoing rehabilitation programs is associated with plasma levels of hemostasis inhibitors 75
Factor VII gene polymorphisms contribute about one third of the factor VII level variation in plasma 75
Hyperhomocysteinemia and a common methylene-tetrahydrofolate reductase mutation (Ala223Val MTHFR) are not associated with a history of thrombosis in patients with inherited thrombophilia 74
Two mutations causing complete androgen insensitivity: a frame-shift in the steroid binding domain and a Cys→Phe substitution in the second zinc finger of the androgen receptor 73
A family study of FVII genotype, elevated levels of factor VII and arterial thrombotic disease 73
Expression Profiles of the Internal Jugular and Saphenous Veins: Focus on Hemostasis Genes 73
An Italian Family with a Novel Mutation Causing Type 2A von Willebrand Disease and with Reduced Levels of von Willebrand Factor not Linked with the von Willebrand Factor Gene. 73
Molecular genetics and biology of congenital hemorrhagic diseases 72
A RECURRENT AMINOACID SUBSTITUTION AND A PARTIAL GENE DELETION IN SEVERE HEMOPHILIA A 71
Sublocalization of von Willebrand factor pseudogene to 22q11.22-q11.23 by in situ hybridization in a 46,X,t(X;22)(pter;q11.21) translocation 70
ALPHA-THALASSEMIA TRAIT IN THE REGION OF FERRARA 70
Identification of a c-myc oncogene lacking the exon 1 in the normal cells of a patient carrying a thyroid carcinoma 69
Totale 9.865
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.528
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 448
Totale 54.976
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.776 492 82 88 385 165 344 222 285 206 341 103 63
2020/20212.223 195 189 148 252 64 202 118 243 58 320 313 121
2021/20221.826 115 191 130 111 114 64 73 80 53 129 153 613
2022/20231.766 189 123 45 215 282 289 74 165 221 14 91 58
2023/2024924 69 91 34 32 64 191 20 62 23 20 24 294
2024/202589 89 0 0 0 0 0 0 0 0 0 0 0
Totale 13.404